Kedudukan dalam Saham
#27833
HeraMED Limited and its associated entities are dedicated to the design,... HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.
Perubahan (1 hari)
-5.41%
Perubahan (1 tahun)
53.47%
Perdagangan HeraMED Limited (HMD)
Harga HMD dengan permodalan pasaran b
Modal pasaran bagi HeraMED Limited(HMD)
Modal Pasaran: $28.60M
Sehingga August 2026, HeraMED Limited mempunyai modal pasaran sebanyak $28.60M. Ini menjadikan HeraMED Limited syarikat ke-27833rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran HeraMED Limited dari 2018 hingga 2026
HMD berbanding dengan 5 teratas yang paling popular stocks
| Harga HMD |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+18,532,557.18%
|
|
|
|
|
$4.634T
|
+16,200,622.01%
|
|
|
|
|
$4.143T
|
+14,484,403.83%
|
|
|
|
|
$3.589T
|
+12,548,904.24%
|
|
|
|
|
$2.857T
|
+9,988,235.83%
|
